New insights into MS treatment
New insights into MS treatment
Data from two Novartis phase III clinical trials show that adding brain shrinkage (brain volume loss) to an existing tool to assess multiple sclerosis activity (m-Rio) will give a more precise prediction of the likelihood of future disability progression.... Read More - http://www.ms-uk.org/gilenya
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post